Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

St. Jude Medical Inc Raises Q4 2012 Guidance


Wednesday, 9 Jan 2013 05:00pm EST 

St. Jude Medical Inc announced that for the fourth quarter of 2012, it expects net sales of approximately $1.372 billion. St. Jude Medical's revenue fell within or exceeded all of the Company's previously announced guidance ranges. St. Jude Medical now projects that adjusted earnings per share will be in the range of $0.90 to $0.92, exceeding the top end of the Company's previously issued guidance by $0.02 to $0.04. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $1.372 billion and EPS of $0.87 for fourth quarter of 2012. 

Company Quote

67.23
1.62 +2.47%
18 Dec 2014